Report Thumbnail
Product Code QY0914213487JOD
Published Date 2026/5/17
English128 PagesGlobal

Global BCI and EEG Market Insights, Forecast to 2032 ‐ Pharmaceutical_LifeSciense Market


Report Thumbnail
Product Code QY0914213487JOD◆An updated version may be available. We will check for you.
Published Date 2026/5/17
English 128 PagesGlobal

Global BCI and EEG Market Insights, Forecast to 2032 ‐ Pharmaceutical_LifeSciense Market



Abstract


Summary

This report covers market analysis of BCI and EGG. A brain–computer interface (BCI), sometimes called a neural-control interface (NCI), mind-machine interface (MMI), direct neural interface (DNI), or brain–machine interface (BMI), is a direct communication pathway between an enhanced or wired brain and an external device.
An EEG, or electroencephalogram, is a test that records the electrical signals of the brain. Doctors use it to help diagnose epilepsy and sleep disorders.
Market Analysis and Insights: Global BCI and EEG Market
The global BCI and EEG market is projected to grow from US$ 780.7 million in 2026 to US$ 1375.6 million by 2032, at a Compound Annual Growth Rate (CAGR) of 9.9% during the forecast period.
Global BCI and EEG main manufactuers include Medtronic, Natus Medical, Nihon Kohden, NeuroPace Inc and Mindmaze SA, totally accounting for about 45% of the market. North America is the largest market of BCI and EEG, holding a share about 40%. As for the application of products, it is widely used in medical and consumer field. The most common application is in medical field, with a share about 80%. As for the types of products, it can be divided into Hardware and Software and Service. The most common type is Hardware, with a share over 77%.
Report Covers:
This report presents an overview of global market for BCI and EEG market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of BCI and EEG, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for BCI and EEG, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the BCI and EEG revenue, market share and industry ranking of main companies, data from 2021 to 2026. Identification of the major stakeholders in the global BCI and EEG market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for BCI and EEG revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Medtronic
Natus Medical
Nihon Kohden
NeuroPace Inc
Mindmaze SA
G.TEC
BrainCo
InteraXon
Brain Products GmbH
EGI
Blackrock Microsystems LLC
Emotiv Inc
Micromed
ANT Neuro B.V
Compumedics Limited
NeuroSky, Inc.
Artinis Medical Systems BV
Cadwell
Advanced Brain Monitoring
NCC Medical
SYMTOP
Neuroelectrics
Segment by Type
Hardware
Software and Service
Segment by Application
Medical
Consumer
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of BCI and EEG in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of BCI and EEG companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, BCI and EEG revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

Table of Contents

  • 1 Report Overview

    • 1.1 Study Scope
    • 1.2 Market Analysis by Type
      • 1.2.1 Global BCI and EEG Market Size Growth Rate by Type, 2021 VS 2025 VS 2032
      • 1.2.2 Hardware
      • 1.2.3 Software and Service
    • 1.3 Market by Application
      • 1.3.1 Global BCI and EEG Market Size Growth Rate by Application, 2021 VS 2025 VS 2032
      • 1.3.2 Medical
      • 1.3.3 Consumer
    • 1.4 Assumptions and Limitations
    • 1.5 Study Objectives
    • 1.6 Years Considered
  • 2 Global Growth Trends

    • 2.1 Global BCI and EEG Market Perspective (2021-2032)
    • 2.2 Global BCI and EEG Growth Trends by Region
      • 2.2.1 BCI and EEG Market Size by Region: 2021 VS 2025 VS 2032
      • 2.2.2 BCI and EEG Historic Market Size by Region (2021-2026)
      • 2.2.3 BCI and EEG Forecasted Market Size by Region (2027-2032)
    • 2.3 BCI and EEG Market Dynamics
      • 2.3.1 BCI and EEG Industry Trends
      • 2.3.2 BCI and EEG Market Drivers
      • 2.3.3 BCI and EEG Market Challenges
      • 2.3.4 BCI and EEG Market Restraints
  • 3 Competition Landscape by Key Players

    • 3.1 Global Revenue BCI and EEG by Players
      • 3.1.1 Global BCI and EEG Revenue by Players (2021-2026)
      • 3.1.2 Global BCI and EEG Revenue Market Share by Players (2021-2026)
    • 3.2 Global BCI and EEG Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    • 3.3 Global Key Players of BCI and EEG, Ranking by Revenue, 2024 VS 2025 VS 2026
    • 3.4 Global BCI and EEG Market Concentration Ratio
      • 3.4.1 Global BCI and EEG Market Concentration Ratio (CR5 and HHI)
      • 3.4.2 Global Top 10 and Top 5 Companies by BCI and EEG Revenue in 2025
    • 3.5 Global Key Players of BCI and EEG Head office and Area Served
    • 3.6 Global Key Players of BCI and EEG, Product and Application
    • 3.7 Global Key Players of BCI and EEG, Date of Enter into This Industry
    • 3.8 Mergers & Acquisitions, Expansion Plans
  • 4 BCI and EEG Breakdown Data by Type

    • 4.1 Global BCI and EEG Historic Market Size by Type (2021-2026)
    • 4.2 Global BCI and EEG Forecasted Market Size by Type (2027-2032)
  • 5 BCI and EEG Breakdown Data by Application

    • 5.1 Global BCI and EEG Historic Market Size by Application (2021-2026)
    • 5.2 Global BCI and EEG Forecasted Market Size by Application (2027-2032)
  • 6 North America

    • 6.1 North America BCI and EEG Market Size (2021-2032)
    • 6.2 North America BCI and EEG Market Size by Type
      • 6.2.1 North America BCI and EEG Market Size by Type (2021-2026)
      • 6.2.2 North America BCI and EEG Market Size by Type (2027-2032)
      • 6.2.3 North America BCI and EEG Market Share by Type (2021-2032)
    • 6.3 North America BCI and EEG Market Size by Application
      • 6.3.1 North America BCI and EEG Market Size by Application (2021-2026)
      • 6.3.2 North America BCI and EEG Market Size by Application (2027-2032)
      • 6.3.3 North America BCI and EEG Market Share by Application (2021-2032)
    • 6.4 North America BCI and EEG Market Size by Country
      • 6.4.1 North America BCI and EEG Market Size by Country: 2021 VS 2025 VS 2032
      • 6.4.2 North America BCI and EEG Market Size by Country (2021-2026)
      • 6.4.3 North America BCI and EEG Market Size by Country (2027-2032)
      • 6.4.4 United States
      • 6.4.5 Canada
  • 7 Europe

    • 7.1 Europe BCI and EEG Market Size (2021-2032)
    • 7.2 Europe BCI and EEG Market Size by Type
      • 7.2.1 Europe BCI and EEG Market Size by Type (2021-2026)
      • 7.2.2 Europe BCI and EEG Market Size by Type (2027-2032)
      • 7.2.3 Europe BCI and EEG Market Share by Type (2021-2032)
    • 7.3 Europe BCI and EEG Market Size by Application
      • 7.3.1 Europe BCI and EEG Market Size by Application (2021-2026)
      • 7.3.2 Europe BCI and EEG Market Size by Application (2027-2032)
      • 7.3.3 Europe BCI and EEG Market Share by Application (2021-2032)
    • 7.4 Europe BCI and EEG Market Size by Country
      • 7.4.1 Europe BCI and EEG Market Size by Country: 2021 VS 2025 VS 2032
      • 7.4.2 Europe BCI and EEG Market Size by Country (2021-2026)
      • 7.4.3 Europe BCI and EEG Market Size by Country (2027-2032)
      • 7.4.3 Germany
      • 7.4.4 France
      • 7.4.5 U.K.
      • 7.4.6 Italy
      • 7.4.7 Russia
      • 7.4.8 Nordic Countries
  • 8 China

    • 8.1 China BCI and EEG Market Size (2021-2032)
    • 8.2 China BCI and EEG Market Size by Type
      • 8.2.1 China BCI and EEG Market Size by Type (2021-2026)
      • 8.2.2 China BCI and EEG Market Size by Type (2027-2032)
      • 8.2.3 China BCI and EEG Market Share by Type (2021-2032)
    • 8.3 China BCI and EEG Market Size by Application
      • 8.3.1 China BCI and EEG Market Size by Application (2021-2026)
      • 8.3.2 China BCI and EEG Market Size by Application (2027-2032)
      • 8.3.3 China BCI and EEG Market Share by Application (2021-2032)
  • 9 Asia (excluding China)

    • 9.1 Asia BCI and EEG Market Size (2021-2032)
    • 9.2 Asia BCI and EEG Market Size by Type
      • 9.2.1 Asia BCI and EEG Market Size by Type (2021-2026)
      • 9.2.2 Asia BCI and EEG Market Size by Type (2027-2032)
      • 9.2.3 Asia BCI and EEG Market Share by Type (2021-2032)
    • 9.3 Asia BCI and EEG Market Size by Application
      • 9.3.1 Asia BCI and EEG Market Size by Application (2021-2026)
      • 9.3.2 Asia BCI and EEG Market Size by Application (2027-2032)
      • 9.3.3 Asia BCI and EEG Market Share by Application (2021-2032)
    • 9.4 Asia BCI and EEG Market Size by Region
      • 9.4.1 Asia BCI and EEG Market Size by Region: 2021 VS 2025 VS 2032
      • 9.4.2 Asia BCI and EEG Market Size by Region (2021-2026)
      • 9.4.3 Asia BCI and EEG Market Size by Region (2027-2032)
      • 9.4.4 Japan
      • 9.4.5 South Korea
      • 9.4.6 China Taiwan
      • 9.4.7 Southeast Asia
      • 9.4.8 India
      • 9.4.9 Australia
  • 10 Middle East, Africa, and Latin America

    • 10.1 Middle East, Africa, and Latin America BCI and EEG Market Size (2021-2032)
    • 10.2 Middle East, Africa, and Latin America BCI and EEG Market Size by Type
      • 10.2.1 Middle East, Africa, and Latin America BCI and EEG Market Size by Type (2021-2026)
      • 10.2.2 Middle East, Africa, and Latin America BCI and EEG Market Size by Type (2027-2032)
      • 10.2.3 Middle East, Africa, and Latin America BCI and EEG Market Share by Type (2021-2032)
    • 10.3 Middle East, Africa, and Latin America BCI and EEG Market Size by Application
      • 10.3.1 Middle East, Africa, and Latin America BCI and EEG Market Size by Application (2021-2026)
      • 10.3.2 Middle East, Africa, and Latin America BCI and EEG Market Size by Application (2027-2032)
      • 10.3.3 Middle East, Africa, and Latin America BCI and EEG Market Share by Application (2021-2032)
    • 10.4 Middle East, Africa, and Latin America BCI and EEG Market Size by Country
      • 10.4.1 Middle East, Africa, and Latin America BCI and EEG Market Size by Country: 2021 VS 2025 VS 2032
      • 10.4.2 Middle East, Africa, and Latin America BCI and EEG Market Size by Country (2021-2026)
      • 10.4.3 Middle East, Africa, and Latin America BCI and EEG Market Size by Country (2027-2032)
      • 10.4.4 Brazil
      • 10.4.5 Mexico
      • 10.4.6 Turkey
      • 10.4.7 Saudi Arabia
      • 10.4.8 Israel
      • 10.4.9 GCC Countries
  • 11 Key Players Profiles

    • 11.1 Medtronic
      • 11.1.1 Medtronic Company Details
      • 11.1.2 Medtronic Business Overview
      • 11.1.3 Medtronic BCI and EEG Introduction
      • 11.1.4 Medtronic Revenue in BCI and EEG Business (2021-2026)
      • 11.1.5 Medtronic Recent Developments
    • 11.2 Natus Medical
      • 11.2.1 Natus Medical Company Details
      • 11.2.2 Natus Medical Business Overview
      • 11.2.3 Natus Medical BCI and EEG Introduction
      • 11.2.4 Natus Medical Revenue in BCI and EEG Business (2021-2026)
      • 11.2.5 Natus Medical Recent Developments
    • 11.3 Nihon Kohden
      • 11.3.1 Nihon Kohden Company Details
      • 11.3.2 Nihon Kohden Business Overview
      • 11.3.3 Nihon Kohden BCI and EEG Introduction
      • 11.3.4 Nihon Kohden Revenue in BCI and EEG Business (2021-2026)
      • 11.3.5 Nihon Kohden Recent Developments
    • 11.4 NeuroPace Inc
      • 11.4.1 NeuroPace Inc Company Details
      • 11.4.2 NeuroPace Inc Business Overview
      • 11.4.3 NeuroPace Inc BCI and EEG Introduction
      • 11.4.4 NeuroPace Inc Revenue in BCI and EEG Business (2021-2026)
      • 11.4.5 NeuroPace Inc Recent Developments
    • 11.5 Mindmaze SA
      • 11.5.1 Mindmaze SA Company Details
      • 11.5.2 Mindmaze SA Business Overview
      • 11.5.3 Mindmaze SA BCI and EEG Introduction
      • 11.5.4 Mindmaze SA Revenue in BCI and EEG Business (2021-2026)
      • 11.5.5 Mindmaze SA Recent Developments
    • 11.6 G.TEC
      • 11.6.1 G.TEC Company Details
      • 11.6.2 G.TEC Business Overview
      • 11.6.3 G.TEC BCI and EEG Introduction
      • 11.6.4 G.TEC Revenue in BCI and EEG Business (2021-2026)
      • 11.6.5 G.TEC Recent Developments
    • 11.7 BrainCo
      • 11.7.1 BrainCo Company Details
      • 11.7.2 BrainCo Business Overview
      • 11.7.3 BrainCo BCI and EEG Introduction
      • 11.7.4 BrainCo Revenue in BCI and EEG Business (2021-2026)
      • 11.7.5 BrainCo Recent Developments
    • 11.8 InteraXon
      • 11.8.1 InteraXon Company Details
      • 11.8.2 InteraXon Business Overview
      • 11.8.3 InteraXon BCI and EEG Introduction
      • 11.8.4 InteraXon Revenue in BCI and EEG Business (2021-2026)
      • 11.8.5 InteraXon Recent Developments
    • 11.9 Brain Products GmbH
      • 11.9.1 Brain Products GmbH Company Details
      • 11.9.2 Brain Products GmbH Business Overview
      • 11.9.3 Brain Products GmbH BCI and EEG Introduction
      • 11.9.4 Brain Products GmbH Revenue in BCI and EEG Business (2021-2026)
      • 11.9.5 Brain Products GmbH Recent Developments
    • 11.10 EGI
      • 11.10.1 EGI Company Details
      • 11.10.2 EGI Business Overview
      • 11.10.3 EGI BCI and EEG Introduction
      • 11.10.4 EGI Revenue in BCI and EEG Business (2021-2026)
      • 11.10.5 EGI Recent Developments
    • 11.11 Blackrock Microsystems LLC
      • 11.11.1 Blackrock Microsystems LLC Company Details
      • 11.11.2 Blackrock Microsystems LLC Business Overview
      • 11.11.3 Blackrock Microsystems LLC BCI and EEG Introduction
      • 11.11.4 Blackrock Microsystems LLC Revenue in BCI and EEG Business (2021-2026)
      • 11.11.5 Blackrock Microsystems LLC Recent Developments
    • 11.12 Emotiv Inc
      • 11.12.1 Emotiv Inc Company Details
      • 11.12.2 Emotiv Inc Business Overview
      • 11.12.3 Emotiv Inc BCI and EEG Introduction
      • 11.12.4 Emotiv Inc Revenue in BCI and EEG Business (2021-2026)
      • 11.12.5 Emotiv Inc Recent Developments
    • 11.13 Micromed
      • 11.13.1 Micromed Company Details
      • 11.13.2 Micromed Business Overview
      • 11.13.3 Micromed BCI and EEG Introduction
      • 11.13.4 Micromed Revenue in BCI and EEG Business (2021-2026)
      • 11.13.5 Micromed Recent Developments
    • 11.14 ANT Neuro B.V
      • 11.14.1 ANT Neuro B.V Company Details
      • 11.14.2 ANT Neuro B.V Business Overview
      • 11.14.3 ANT Neuro B.V BCI and EEG Introduction
      • 11.14.4 ANT Neuro B.V Revenue in BCI and EEG Business (2021-2026)
      • 11.14.5 ANT Neuro B.V Recent Developments
    • 11.15 Compumedics Limited
      • 11.15.1 Compumedics Limited Company Details
      • 11.15.2 Compumedics Limited Business Overview
      • 11.15.3 Compumedics Limited BCI and EEG Introduction
      • 11.15.4 Compumedics Limited Revenue in BCI and EEG Business (2021-2026)
      • 11.15.5 Compumedics Limited Recent Developments
    • 11.16 NeuroSky, Inc.
      • 11.16.1 NeuroSky, Inc. Company Details
      • 11.16.2 NeuroSky, Inc. Business Overview
      • 11.16.3 NeuroSky, Inc. BCI and EEG Introduction
      • 11.16.4 NeuroSky, Inc. Revenue in BCI and EEG Business (2021-2026)
      • 11.16.5 NeuroSky, Inc. Recent Developments
    • 11.17 Artinis Medical Systems BV
      • 11.17.1 Artinis Medical Systems BV Company Details
      • 11.17.2 Artinis Medical Systems BV Business Overview
      • 11.17.3 Artinis Medical Systems BV BCI and EEG Introduction
      • 11.17.4 Artinis Medical Systems BV Revenue in BCI and EEG Business (2021-2026)
      • 11.17.5 Artinis Medical Systems BV Recent Developments
    • 11.18 Cadwell
      • 11.18.1 Cadwell Company Details
      • 11.18.2 Cadwell Business Overview
      • 11.18.3 Cadwell BCI and EEG Introduction
      • 11.18.4 Cadwell Revenue in BCI and EEG Business (2021-2026)
      • 11.18.5 Cadwell Recent Developments
    • 11.19 Advanced Brain Monitoring
      • 11.19.1 Advanced Brain Monitoring Company Details
      • 11.19.2 Advanced Brain Monitoring Business Overview
      • 11.19.3 Advanced Brain Monitoring BCI and EEG Introduction
      • 11.19.4 Advanced Brain Monitoring Revenue in BCI and EEG Business (2021-2026)
      • 11.19.5 Advanced Brain Monitoring Recent Developments
    • 11.20 NCC Medical
      • 11.20.1 NCC Medical Company Details
      • 11.20.2 NCC Medical Business Overview
      • 11.20.3 NCC Medical BCI and EEG Introduction
      • 11.20.4 NCC Medical Revenue in BCI and EEG Business (2021-2026)
      • 11.20.5 NCC Medical Recent Developments
    • 11.21 SYMTOP
      • 11.21.1 SYMTOP Company Details
      • 11.21.2 SYMTOP Business Overview
      • 11.21.3 SYMTOP BCI and EEG Introduction
      • 11.21.4 SYMTOP Revenue in BCI and EEG Business (2021-2026)
      • 11.21.5 SYMTOP Recent Developments
    • 11.22 Neuroelectrics
      • 11.22.1 Neuroelectrics Company Details
      • 11.22.2 Neuroelectrics Business Overview
      • 11.22.3 Neuroelectrics BCI and EEG Introduction
      • 11.22.4 Neuroelectrics Revenue in BCI and EEG Business (2021-2026)
      • 11.22.5 Neuroelectrics Recent Developments
  • 12 Analyst's Viewpoints/Conclusions

  • 13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer
    • 13.3 Author Details
USD 4,900 or Partial Purchase
*Prices are subject to change by the publisher.
© 2026 ShareFair Inc.